CRISPR Delivery Challenges and Applications within Pharma

CRISPR is now one of the most affordable forms of gene editing causing a boom in R&D over the last few years. However, the technique does have its limitations which include maintaining end to end control on geneti manipulation, avoiding off targets effects and pathway recovery post double strand break. Ahead of the 2017 CRISPR summit Javier Terriente, CSO, ZeClinics and Danilo Maddalo Lab Head ONC Pharmacology, Novartis Institutes for BioMedical Research discuss the latest regarding CRISPR delivery challenges and applications within Pharma.

Spotlight

Smith & Nephew Orthopaedics

Smith & Nephew develops and markets advanced medical devices that help healthcare professionals treat patients more effectively - and patients get back to their lives faster. Our dedicated Global Business Units are - Orthopaedic Reconstruction, Orthopaedic Trauma, Clinical Therapies and Advanced Wound Divisions

OTHER WHITEPAPERS
news image

Three Challenges Facing Study Start Up and the Low-Code Solution

whitePaper | December 22, 2022

The life sciences industry has been exploring ways to accelerate the study start up process for well over a decade. The industry has long understood the value behind faster clinical trials: the sooner clinical trial results can be delivered to agencies, the sooner a new treatment can be available for patients.

Read More
news image

Discovering Effective Strategies for Sales and Marketing in the Face of Reduced Access to Oncologists

whitePaper | January 15, 2023

Oncology breakthroughs are currently fueling significant growth in the market, as well as the competition between pharmaceutical brands for market share. As increasingly individualized cancer treatments become available,

Read More
news image

The Ultimate Guide to Digitizing Pharma Manufacturing

whitePaper | September 15, 2022

The sheer size of the pharmaceutical industry makes it important for all stakeholders to stay up to date with pharmaceutical industry trends.

Read More
news image

A pragmatic approach to developing rare disease drug

whitePaper | July 13, 2023

Most medicines in development today target diseases affecting large sections of the global population. But now we are slowly beginning to see a rise in the interest of developing ”orphan drugs,” or pharmaceutical agents intended to treat rare diseases.

Read More
news image

BUILDING A TOMORROW-READY LAB

whitePaper | September 8, 2022

Charles Darwin famously said on survival, "It is not the strongest of the species that survives, nor the most intelligent; it is the one most adaptable to change." Resilience has become an essential message in today's post-covid, next-normal world.

Read More
news image

Ultrasafe film Ultra-high barrier Product stability Patient safety

whitePaper | December 22, 2022

Every viable pharmaceutical packaging system must comprise materials proven to protect its contents against moisture and other atmospheric variables, and be safe for use with the specified dosage form and the route of administration1

Read More

Spotlight

Smith & Nephew Orthopaedics

Smith & Nephew develops and markets advanced medical devices that help healthcare professionals treat patients more effectively - and patients get back to their lives faster. Our dedicated Global Business Units are - Orthopaedic Reconstruction, Orthopaedic Trauma, Clinical Therapies and Advanced Wound Divisions

Events